A Novel Amphibian Antimicrobial Peptide, Phylloseptin-PV1, Exhibits Effective Anti-staphylococcal Activity Without Inducing Either Hepatic or Renal Toxicity in Mice

Frontiers in Microbiology
Yue LiuLei Wang

Abstract

In order to part address the problem of drug-resistant pathogens, antimicrobial peptides (AMPs) have been proposed as alternatives to traditional antibiotics. Herein, a novel phylloseptin peptide, named phylloseptin-PV1 (PPV1), is described from the defensive skin secretion of the Neotropical white-lined leaf frog, Phyllomedusa vaillantii. The peptide was synthesized by solid phase peptide synthesis (SPPS) and purified by RP-HPLC, prior to assessment of its biological activities. PPV1 not only demonstrated potent antimicrobial activity against planktonic ESKAPE microorganisms and the yeast, Candida albicans, but also inhibited and eradicated Staphylococcus aureus and MRSA biofilms. The antimicrobial mechanism was shown to include permeabilization of target cell membranes. The in vivo antimicrobial activity of the peptide was then evaluated using mice. PPV1 also exhibited antiproliferative activity against the cancer cell lines, H157, MCF-7, and U251MG, but had a lower potency against the normal cell line, HMEC-1. Although, the peptide possessed a moderate hemolytic action on mammalian red blood cells in vitro, it did not induce significant hepatic or renal toxicity in injected infected mice. These studies have thus found PPV1 t...Continue Reading

References

Dec 1, 1992·Journal of Pharmacological and Toxicological Methods·M J TylerJ H Bowie
Jan 1, 1997·Toxicon : Official Journal of the International Society on Toxinology·C L OwnbyJ E Fletcher
Oct 20, 1998·The Journal of Hospital Infection·T OharaK Itoh
Mar 2, 2002·The Lancet Infectious Diseases·R E Hancock
Nov 24, 2004·Infection and Immunity·Miguel A CamposJosé A Bengoechea
May 9, 2007·Journal of Peptide Science : an Official Publication of the European Peptide Society·Alessandro PiniLuisa Bracci
Jun 15, 2007·Toxicon : Official Journal of the International Society on Toxinology·J Michael ConlonLouise A Rollins-Smith
Jul 12, 2007·Seminars in Immunopathology·Katherine Radek, Richard Gallo
Dec 15, 2007·Biochimica Et Biophysica Acta·David W Hoskin, Ayyalusamy Ramamoorthy
Oct 20, 2009·European Journal of Pharmacology·Frank Schweizer
Jan 15, 2014·Antimicrobial Agents and Chemotherapy·Harini Mohanram, Surajit Bhattacharjya
Apr 9, 2014·Journal of Immunological Methods·Tobias M Hohl
May 24, 2014·PLoS Pathogens·César de la Fuente-NúñezRobert E W Hancock
Mar 1, 2016·Applied Microbiology and Biotechnology·Philipp StiefelQun Ren
Mar 26, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sapir Ron-DoitchSteffen Rupp
Jul 12, 2017·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Pooi Yin Chung, Ramona Khanum
Aug 30, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Natalia MolchanovaHenrik Franzyk
Oct 28, 2017·Frontiers in Microbiology·Christopher J Anderson, Melissa M Kendall
Nov 8, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xianhui WuTianbao Chen
Apr 14, 2019·Advances in Experimental Medicine and Biology·Michael Zasloff
Jun 14, 2019·Infection and Drug Resistance·Shamshul AnsariAhmed Morad Asaad
Mar 17, 2020·Current Opinion in Microbiology·Jakub M Kwiecinski, Alexander R Horswill
Jun 25, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anna Lucia TorneselloMaria Lina Tornesello

❮ Previous
Next ❯

Datasets Mentioned

BETA
MT497983

Methods Mentioned

BETA
amidation
PCR
circular dichroism
ELISA

Clinical Trials Mentioned

NCT01590758

Software Mentioned

BESTSEL
GraphPad Prism
Prism
Proteome Discoverer
K2D3
TASSER
Patchdock

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.